How do the results of KEYNOTE-B15/EV-304 influence your preferred treatment for cisplatin eligible MIBC?   

Which patients will you still use perioperative durva/cis/gem? Are there toxicities you've encountered that don't overlap where you could be a cis/gem candidate but not an EV candidate?